SRXH Quote, Financials, Valuation and Earnings

Pediatrix Medical Group, Inc. has a net margin of -13.47% compared to SRx Health Solutions, Inc.'s net margin of 14.55%. SRx Health Solutions, Inc.'s return on equity of -- beat Pediatrix Medical Group, Inc.'s return on equity of 20.22%.

SRx Health Solutions, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Pediatrix Medical Group, Inc. has an analysts' consensus of $22.67 which suggests that it could fall by -2.68%. Given that Pediatrix Medical Group, Inc. has higher upside potential than SRx Health Solutions, Inc., analysts believe Pediatrix Medical Group, Inc. is more attractive than SRx Health Solutions, Inc..

SRx Health Solutions, Inc. has a beta of 0.929, which suggesting that the stock is 7.069% less volatile than S&P 500. In comparison Pediatrix Medical Group, Inc. has a beta of 0.766, suggesting its less volatile than the S&P 500 by 23.447%.

SRx Health Solutions, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Pediatrix Medical Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SRx Health Solutions, Inc. pays -- of its earnings as a dividend. Pediatrix Medical Group, Inc. pays out -- of its earnings as a dividend.

SRx Health Solutions, Inc. quarterly revenues are $7.2M, which are smaller than Pediatrix Medical Group, Inc. quarterly revenues of $492.9M. SRx Health Solutions, Inc.'s net income of -$964K is lower than Pediatrix Medical Group, Inc.'s net income of $71.7M. Notably, SRx Health Solutions, Inc.'s price-to-earnings ratio is 0.14x while Pediatrix Medical Group, Inc.'s PE ratio is 12.29x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SRx Health Solutions, Inc. is 0.07x versus 1.04x for Pediatrix Medical Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Kindly MD, Inc. has a net margin of -13.47% compared to SRx Health Solutions, Inc.'s net margin of -22162.75%. SRx Health Solutions, Inc.'s return on equity of -- beat Kindly MD, Inc.'s return on equity of -91.57%.

SRx Health Solutions, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Kindly MD, Inc. has an analysts' consensus of $1.25 which suggests that it could grow by 130.2%. Given that Kindly MD, Inc. has higher upside potential than SRx Health Solutions, Inc., analysts believe Kindly MD, Inc. is more attractive than SRx Health Solutions, Inc..

SRx Health Solutions, Inc. has a beta of 0.929, which suggesting that the stock is 7.069% less volatile than S&P 500. In comparison Kindly MD, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

SRx Health Solutions, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Kindly MD, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SRx Health Solutions, Inc. pays -- of its earnings as a dividend. Kindly MD, Inc. pays out -- of its earnings as a dividend.

SRx Health Solutions, Inc. quarterly revenues are $7.2M, which are larger than Kindly MD, Inc. quarterly revenues of $388.2K. SRx Health Solutions, Inc.'s net income of -$964K is higher than Kindly MD, Inc.'s net income of -$86M. Notably, SRx Health Solutions, Inc.'s price-to-earnings ratio is 0.14x while Kindly MD, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SRx Health Solutions, Inc. is 0.07x versus 15.22x for Kindly MD, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

The Oncology Institute, Inc. has a net margin of -13.47% compared to SRx Health Solutions, Inc.'s net margin of -10.08%. SRx Health Solutions, Inc.'s return on equity of -- beat The Oncology Institute, Inc.'s return on equity of -9486.64%.

SRx Health Solutions, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand The Oncology Institute, Inc. has an analysts' consensus of $6.50 which suggests that it could grow by 111.73%. Given that The Oncology Institute, Inc. has higher upside potential than SRx Health Solutions, Inc., analysts believe The Oncology Institute, Inc. is more attractive than SRx Health Solutions, Inc..

SRx Health Solutions, Inc. has a beta of 0.929, which suggesting that the stock is 7.069% less volatile than S&P 500. In comparison The Oncology Institute, Inc. has a beta of 0.162, suggesting its less volatile than the S&P 500 by 83.817%.

SRx Health Solutions, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Oncology Institute, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SRx Health Solutions, Inc. pays -- of its earnings as a dividend. The Oncology Institute, Inc. pays out -- of its earnings as a dividend.

SRx Health Solutions, Inc. quarterly revenues are $7.2M, which are smaller than The Oncology Institute, Inc. quarterly revenues of $136.6M. SRx Health Solutions, Inc.'s net income of -$964K is higher than The Oncology Institute, Inc.'s net income of -$13.8M. Notably, SRx Health Solutions, Inc.'s price-to-earnings ratio is 0.14x while The Oncology Institute, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SRx Health Solutions, Inc. is 0.07x versus 0.57x for The Oncology Institute, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

U.S. Physical Therapy, Inc. has a net margin of -13.47% compared to SRx Health Solutions, Inc.'s net margin of 9.98%. SRx Health Solutions, Inc.'s return on equity of -- beat U.S. Physical Therapy, Inc.'s return on equity of 8.6%.

SRx Health Solutions, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand U.S. Physical Therapy, Inc. has an analysts' consensus of $105.17 which suggests that it could grow by 39.68%. Given that U.S. Physical Therapy, Inc. has higher upside potential than SRx Health Solutions, Inc., analysts believe U.S. Physical Therapy, Inc. is more attractive than SRx Health Solutions, Inc..

SRx Health Solutions, Inc. has a beta of 0.929, which suggesting that the stock is 7.069% less volatile than S&P 500. In comparison U.S. Physical Therapy, Inc. has a beta of 1.320, suggesting its more volatile than the S&P 500 by 32.001%.

SRx Health Solutions, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. U.S. Physical Therapy, Inc. offers a yield of 2.39% to investors and pays a quarterly dividend of $0.45 per share. SRx Health Solutions, Inc. pays -- of its earnings as a dividend. U.S. Physical Therapy, Inc. pays out 95.62% of its earnings as a dividend. U.S. Physical Therapy, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

SRx Health Solutions, Inc. quarterly revenues are $7.2M, which are smaller than U.S. Physical Therapy, Inc. quarterly revenues of $197.1M. SRx Health Solutions, Inc.'s net income of -$964K is lower than U.S. Physical Therapy, Inc.'s net income of $19.7M. Notably, SRx Health Solutions, Inc.'s price-to-earnings ratio is 0.14x while U.S. Physical Therapy, Inc.'s PE ratio is 31.72x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SRx Health Solutions, Inc. is 0.07x versus 1.51x for U.S. Physical Therapy, Inc.. Usually stocks with elevated PS ratios are considered overvalued.